Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Olon S.p.A. announced the start of the construction of a new GMP manufacturing facility at its microbial CDMO facility located in Capua, Italy.
read more
Tuesday, September 04, 2018
Olon S.p.A. announced the acquisition of a local generics chemical operations API manufacturing facility in Mahad, India, as part of a continuing expansion of its global footprint.
read more
Ology Bioservices and Inovio announced the DOD has awarded Ology Bioservices with a contract to work with Inovio on DNA technology transfer to rapidly manufacture DNA vaccines.
read more
Ology Bioservices announced the Department of Defense has awarded the company with two contracts valued at $135.4 million.
read more
Oakrum Pharma has entered into an agreement with Biophore to develop and manufacture two prescription generic pharmaceutical products that are intended to be commercialized in the U.S.
read more
Friday, February 07, 2014
Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio),
a biotechnology company developing DCVax® personalized immune therapies for solid tumor
cancers, announced today that it has entered into a set of agreements for large-scale expansion of
the ...
read more
Monday, September 07, 2020
Nutriband has completed the acquisition of Pocono Coated Product's Transdermal and Health product manufacturing business effective August 31, 2020.
read more
Tuesday, February 18, 2020
Nucleus Biologics announced a complete line of cGMP grade media and a new supplement to enable improved insulin response and standardized processing of human pancreatic islets and beta cells.
read more
To mark its 10th anniversary, NuChem Sciences, Canada's largest contract research organization (CRO) in drug discovery chemistry, recently inaugurated its new laboratories located on Dobrin Street in Montreal.
read more
NSF International is now offering pharma biotech consulting and training services from its Gurugram, India office.
read more
Work to be showcased at the 2013 Controlled Release Society annual meeting shows that Hyasis®, the Bacillus-derived Hyaluronic acid from Novozymes Biopharma, helps formulation scientists meet emerging challenges in drug development with controlled ...
read more
For the first time, Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, will showcase its biological-based ingredients and technologies at CPhI China. The company’s Hyasis™, Recombumin® and biocatalysis products will feature ...
read more
Novozymes Biopharma has entered a new collaborative research agreement with one of the world’s top vaccine companies. The partnership will enable the company to evaluate Novozymes Biopharma's modified recombinant human albumin (rAlbumin) Veltis ...
read more
Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, has today announced a collaboration with Janssen Research & Development, LLC (Janssen). The agreement will enable Janssen to evaluate Novozymes Biopharma’s engineered ...
read more
Monday, November 13, 2017
Novo Nordisk has awarded Emerson a $40 million automation systems and services contract for a new U.S.-based drug manufacturing facility to address the global diabetes epidemic.
read more